Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,274

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,274 results for “disease models”

Learn how ShareScore rates datasets ↗
zenodo32/100

Data associated to the study entitled:"Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI"

<p>Parkinson&rsquo;s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology.</p> <p>We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted.</p> <p>The shared datafile corresponds to the MRI biomarkers extracted from diffusion and functional acquisitions as well as from histological mesaurements within striatum and substantia nigria.</p>

opencc-by-nc-4.0Aug 2018View details →
zenodo32/100

A Model for the Development of Alzheimer's Disease

<p>Here is the code and supplementary data for the paper "A Model for the Development of Alzheimer&rsquo;s Disease". The file Alzheimer-model.code.tar.gz contains the code. Supplementary Data.rar includes supplementary data S1 to S7. Supplementary data S1 contains all transcript sequences of the groups, supplementary data S2 contains the genome annotation file assembled by StringTie, supplementary data S3 contains the TPM expression files of all assembled transcripts, supplementary data S4 contains the differential transcripts files, supplementary data S5 contains the functional annotation files of protein-coding transcripts, supplementary data S6 contains the pathways enriched by all differential transcripts, and supplementary data S7 contains information of all samples.</p>

opencc-by-4.0Aug 2024View details →
zenodo32/100

Understanding the Rare Inflammatory Disease Using Large Language Models and Social Media Data

Open the record for dataset details and reuse information.

opencc-by-4.0Apr 2024View details →
zenodo32/100

Global Transcriptomic Analysis of Topical Sodium Alginate Protection Against Peptic Damage in An In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease

<p>PA= pepsin + Acid; "Sham + PA" means "Pretreatment + Treatment"</p> <p><span>Breakthrough symptoms </span>are thought to occur in roughly half of <span>all </span>gastroesophageal reflux disease (GERD) patients despite maximal acid suppression (proton pump inhibitor, PPI) therapy. Topical alginates have recently been shown to enhance mucosal defense against acid-pepsin insult during GERD. We aimed to examine potential alginate protection of transcriptomic changes in a cell culture model of PPI recalcitrant GERD. Immortalized normal-derived human esophageal epithelial cells underwent pretreatment with&nbsp;commercial alginate-based anti-reflux medications (Gaviscon Advance or Gaviscon Double Action), a matched-viscosity placebo control, or pH 7.4 buffer (sham) alone for 1 minute, followed by exposure to pH 6.0+pepsin or buffer alone for 3 minutes. RNA sequencing was conducted, and Ingenuity Pathway Analysis was performed with a false discovery rate of &le;0.01, and absolute fold-change of &ge;<span>1.3. Pepsin-acid exposure disrupted gene expressions associated with epithelial barrier function, chromatin structure</span>, carcinogenesis, and inflammation<span>. Alginate formulations demonstrated protection by mitigating these changes and promoting extracellular matrix repair, downregulating proto-oncogenes, and enhancing tumor suppressor expression. </span>These data suggest molecular mechanisms by which alginates provide topical protection against injury during weakly acidic reflux and support a potential role for alginates in prevention of GERD-related carcinogenesis.</p>

opencc-by-4.0Sep 2024View details →
zenodo32/100

Dataset supporting the manuscript "Establishment of a Newborn Lamb Gut-Loop Model to Evaluate New Methods of Enteric Disease Control and Reduce Experimental Animal Use" (Baillou, Kasal-Hoc et al, Veterinary Sciences, 2021)

<p>These are the data supporting reported results in the publication &quot;Establishment of a Newborn Lamb Gut-Loop Model to Evaluate New Methods of Enteric Disease Control and Reduce Experimental Animal Use&quot; (Baillou, A, Kasal-Hoc N. et al, Veterinary Sciences, 2021). DOI not yet available.</p>

opencc-by-4.0Aug 2021View details →
zenodo32/100

Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho during almost two years of pandemic

<p>These are pseudo-randomized data from the MISTRAL study: &quot;Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho during almost two years of pandemic&quot;.&nbsp; The data dictionary explains the data. Between December 2020 and August 2022, 4371 individuals with either COVID symptoms or contact with a COVID-positive case were included from two hospitals in Lesotho.&nbsp;</p>

opencc-by-4.0Apr 2023View details →
zenodo32/100

rMATS analysis of alternative splicing events in a mouse model of environmental liver disease

<p>rMATS (https://rnaseq-mats.sourceforge.io/)&nbsp;was used to identify differential alternative splicing events (ASEs) corresponding to all five major types of AS patterns, <em>i.e</em>., skipped exon (SE), mutually exclusive exons (MXE), alternative 3&rsquo; splice site (A3SS), alternative 5&rsquo; splice site (A5SS), and retained intron (RI), in the HFD-fed mouse livers exposed to Ar1260, PCB126, or Ar1260 + PCB126 co-exposure compared to vehicle control This dataset identifies differential ASEs corresponding to all five major types of AS patterns [<em>i.e.,</em> skipped exon (SE), mutually exclusive exons (MXE), alternative 3&rsquo; splice site (A3&rsquo;SS), alternative 5&rsquo; splice site (A5&rsquo;SS), and retained intron (RI)], between Ar1260, PCB126, and Ar1260 + PCB126-exposed samples and vehicle control. For each ASE, the estimation of the alternatively spliced region usage is defined as percent-spliced in (&psi; or PSI). Each comparison was made to identify differential ASEs with an associated change in exon usage (∆&psi;). Differential ASEs were detected with an FDR of &lt;0.05 and |∆&psi;| of&ge;5%. The difference in the proportion of the two isoforms of the transcript was expressed as the change in mean percentage spliced-inform included (mean ∆&psi;).</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov32/100

Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty. A Single-center,

ClinicalTrials.gov study NCT07000097. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients

ClinicalTrials.gov study NCT05719766. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Prediction Model of Cardiac Risk for Dental Extraction in Elderly Patients With Cardiovascular Diseases

ClinicalTrials.gov study NCT03211312. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Modeling Patient Response to a Therapeutic Diet in Crohn's Disease

ClinicalTrials.gov study NCT04596566. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Evaluating the Potential of Large Language Models for Respiratory Disease Consultations

ClinicalTrials.gov study NCT06457269. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Research on the Diagnostic Value of Machine Learning Model Based on Clinical Data in Patients With Coronary Heart Disease

ClinicalTrials.gov study NCT05018715. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Develop a Risk Prediction Model for Phthalate-ester-induced Diseases

ClinicalTrials.gov study NCT05892029. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Tissue Models for Invasive Disease (TIMID)

ClinicalTrials.gov study NCT04620824. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Tissue Models for Liver Disease

ClinicalTrials.gov study NCT05255042. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi

ClinicalTrials.gov study NCT05510973. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Investigation of the Effectiveness of a Biopsychosocial-Based Exercise Model in Rheumatic Diseases: A Mixed Methods Research With Patients' Perspectives

ClinicalTrials.gov study NCT05344131. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients

ClinicalTrials.gov study NCT04617431. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

ClinicalTrials.gov study NCT06529744. IPD Sharing: NO. Countries: 1. Publications: 33.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record